0.60Open0.40Pre Close3 Volume10 Open Interest7.50Strike Price180.00Turnover56.84%IV2.13%PremiumDec 20, 2024Expiry Date0.45Intrinsic Value100Multiplier16DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type-0.6689Delta0.4352Gamma11.75Leverage Ratio-0.0091Theta-0.0020Rho-7.86Eff Leverage0.0054Vega
Kezar Life Sciences Stock Discussion
SEC· just
Kezar Life Sciences Announces Cessation of Enrollment and Dosing in the Phase 2b PALIZADE Trial of Zetomipzomib in Active Lupus Nephritis Patients
since I'm Evan McCullouch fans, and ever said he bought $Kezar Life Sciences (KZR.US)$ ... for biotech...
recently he just sold.
$Kezar Life Sciences (KZR.US)$
$LumiraDx (LMDX.US)$
No comment yet